MCID: CHG001
MIFTS: 67

Chagas Disease malady

Categories: Rare diseases, Infectious diseases, Neuronal diseases

Aliases & Classifications for Chagas Disease

About this section
Sources:
2CDC, 11Disease Ontology, 13DISEASES, 30ICD10, 31ICD10 via Orphanet, 32ICD9CM, 38MedlinePlus, 48NIH Rare Diseases, 50Novoseek, 54Orphanet, 62SNOMED-CT, 68UMLS, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Chagas Disease:

Name: Chagas Disease 11 48 54 50 38 2 13 68
American Trypanosomiasis 11 48 54 2
Chagas' Disease with Digestive System Involvement 11
Chagas' Disease with Nervous System Involvement 11
 
Chagas' Disease with Other Organ Involvement 11
South American Trypanosomiasis 48
New World Trypanosomiasis 48
Chagas' Disease 11

Characteristics:

Orphanet epidemiological data:

54
chagas disease:
Inheritance: Not applicable; Prevalence: 6-9/10000 (United States); Age of onset: All ages; Age of death: any age

Classifications:



External Ids:

Disease Ontology11 DOID:12140
ICD9CM32 086.2
Orphanet54 ORPHA3386
UMLS via Orphanet69 C0041234
ICD10 via Orphanet31 B57.0, B57.1, B57.2 B57.3, B57.4, B57.5, more

Summaries for Chagas Disease

About this section
MedlinePlus:38 Chagas disease is caused by a parasite. it is common in latin america but not in the united states. infected blood-sucking bugs, sometimes called kissing bugs, spread it. when the bug bites you, usually on your face, it leaves behind infected waste. you can get the infection if you rub it in your eyes or nose, the bite wound or a cut. the disease can also spread through contaminated food, a blood transfusion, a donated organ or from mother to baby during pregnancy. if you notice symptoms, they might include fever flu-like symptoms a rash a swollen eyelid these early symptoms usually go away. however, if you don't treat the infection, it stays in your body. later, it can cause serious intestinal and heart problems. a physical exam and blood tests can diagnose it. you may also need tests to see whether the disease has affected your intestines and heart. medicines can kill the parasite, especially early on. you can also treat related problems. for example, a pacemaker helps with certain heart complications. there are no vaccines or medicines to prevent chagas disease. if you travel to areas where it occurs, you are at higher risk if you sleep outdoors or in poor housing conditions. it is important to use insecticides to prevent bites, and practice food safety. centers for disease control and prevention

MalaCards based summary: Chagas Disease, also known as american trypanosomiasis, is related to hepatitis and congestive heart failure, and has symptoms including fever, pruritus and Array. An important gene associated with Chagas Disease is TNF (Tumor Necrosis Factor), and among its related pathways are Downstream signaling in naive CD8+ T cells and OX40 Pathway. Affiliated tissues include heart, testes and eye, and related mouse phenotypes are Synthetic lethal with MLN4924 (a NAE inhibitor) and craniofacial.

NIH Rare Diseases:48 Chagas disease is caused by the parasite, trypanosoma cruzi. when a triatomine bug (commonly known as a "kissing bug") infected with this parasite bites you, usually on your face, it leaves behind infected waste which can be spread into your eyes, nose, or a wound. chagas disease can also spread through contaminated food, a blood transfusion, a donated organ or from mother to baby during pregnancy. symptoms can include fever, flu-like symptoms, a rash or swollen eyelid. early symptoms usually go away but if not treated, the infection can later cause serious intestinal and heart problems. chagas disease is common in latin america but not in the united states. last updated: 3/4/2014

CDC:2 Chagas disease is named after the Brazilian physician Carlos Chagas, who discovered the disease in 1909. It is caused by the parasite Trypanosoma cruzi, which is transmitted to animals and people by insect vectors and is found only in the Americas (mainly, in rural areas of Latin America where poverty is widespread). Chagas disease (T. cruzi infection) is also referred to as American trypanosomiasis.

Disease Ontology:11 A trypanosomiasis that is a tropical parasitic disease caused by the flagellate protozoan Trypanosoma cruzi, which is transmitted to humans and other mammals by an insect vector, the blood-sucking assassin bugs of the subfamily Triatominae (family Reduviidae), most commonly species belonging to the Triatoma, Rhodnius, and Panstrongylus genera. The symptoms include fever, fatigue, body aches, headache, rash, loss of appetite, diarrhea, vomiting, swelling of the eyelids and myocarditis.

Wikipedia:71 Chagas disease, also known as American trypanosomiasis, is a tropical parasitic disease caused by the... more...

Related Diseases for Chagas Disease

About this section

Diseases related to Chagas Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 362)
idRelated DiseaseScoreTop Affiliating Genes
1hepatitis29.7IFNG, IL10, IL2, IL6, TNF
2congestive heart failure29.6IFNG, IL10, IL2, IL6, TNF
3neuropathy29.6CXCL8, IL1B, IL6, TLR4, TNF
4trypanosomiasis11.5
5pyridoxal 5'-phosphate-dependent epilepsy10.4IL10, TNF
6intussusception10.4IL1B, TNF
7refractory celiac disease10.4IL10, TGFB1
8cardiomyopathy10.4
9autosomal dominant deafness-onychodystrophy syndrome10.4IFNG, IL2, TNF
10urethral intrinsic sphincter deficiency10.4CCL2, IFNG, TNF
11neurotic disorder10.4IFNG, IL10, TNF
12stocco dos santos syndrome10.4IFNG, IL1B, TNF
13congenital hypothyroidism10.3IL10, TLR2, TNF
14spotted fever10.3TLR2, TLR4, TNF
15distal trisomy 14q10.3IFNG, TGFB1, TNF
16parametritis10.3IFNG, IL2, TNF
17steatitis10.3IL2, TNF
18paralytic poliomyelitis10.3IFNG, IL2, TLR4
19aseptic meningitis10.3TLR2, TLR4, TNF
20rosacea10.3IFNG, IL10, IL1B
21transient tic disorder10.3IL10, IL6, TNF
22discharging ear10.3IFNG, IL10, TGFB1
23parasitic ichthyosporea infectious disease10.3TLR2, TLR4, TNF
24polyarteritis nodosa10.3IFNG, TLR2, TLR4
25venezuelan hemorrhagic fever10.3IFNG, IL2, TNF
26myeloid and lymphoid neoplasms with eosinophilia and abnormalities of pdgfra, pdgfrb, and fgfr110.3CCR5, IFNG, TNF
27idiopathic hypertrophic pachymeningitis10.3IL10, NOS2, TNF
28pseudoainhum10.3IL1B, TLR2, TLR4
29ethmoid sinus cancer10.3IFNG, IL1B, TLR4
30conidiobolomycosis10.3CXCL8, IL10, TNF
31tubular renal disease-cardiomyopathy syndrome10.3IL10, TNF
32lepromatous leprosy10.3IFNG, IL10, IL6
33phlyctenulosis10.3IL10, IL6, TNF
34malignant oculomotor nerve tumor10.3CCL2, IFNG, TGFB1
35megaloblastic anemia10.3IL10, IL1B, TLR4
36reproductive system disease10.3IL10, IL6, TLR2
37anal atresia, hypospadias, and penoscrotal inversion10.3CCL2, IFNG, TLR2
38multiple mitochondrial dysfunctions syndrome10.3IFNG, IL10, IL6
39primary ciliary dyskinesia10.3IL10, IL6, TNF
40handl syndrome10.3CXCL8, TLR2, TNF
41bipolar i disorder10.3IL1B, IL6, TNF
42coronary arterial fistulas10.3CXCL8, IL10, TLR4
43human immunodeficiency virus infectious disease10.3IL1B, IL6, TNF
44measles10.3IL1B, IL6, TNF
45leukoplakia of vagina10.3IL6, TLR2, TNF
46endogenous depression10.3IL2, TLR2, TNF
47preaxial polydactyly of fingers10.3IL6, TGFB1, TNF
48dextrocardia10.3IL1B, IL6, TNF
49oropharynx cancer10.3IFNG, IL10, IL2
50severe combined immunodeficiency, t cell-negative, b-cell/natural killer-cell positive10.3IFNG, IL10, IL2, TNF

Graphical network of the top 20 diseases related to Chagas Disease:



Diseases related to chagas disease

Symptoms & Phenotypes for Chagas Disease

About this section

Human phenotypes related to Chagas Disease:

 54 64 (show all 27)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 edema54 Frequent (79-30%)
2 pallor64 54 Frequent (79-30%) HP:0000980
3 skin rash64 54 Frequent (79-30%) HP:0000988
4 cardiomyopathy64 54 Frequent (79-30%) HP:0001638
5 splenomegaly64 54 Frequent (79-30%) HP:0001744
6 thromboembolism64 54 Frequent (79-30%) HP:0001907
7 fever64 54 Frequent (79-30%) HP:0001945
8 diarrhea64 54 Frequent (79-30%) HP:0002014
9 abdominal pain64 54 Frequent (79-30%) HP:0002027
10 dyspnea64 54 Frequent (79-30%) HP:0002094
11 hepatomegaly64 54 Frequent (79-30%) HP:0002240
12 headache64 54 Frequent (79-30%) HP:0002315
13 lymphadenopathy64 54 Frequent (79-30%) HP:0002716
14 myalgia64 54 Frequent (79-30%) HP:0003326
15 localized skin lesion64 54 Frequent (79-30%) HP:0011355
16 arrhythmia64 54 Frequent (79-30%) HP:0011675
17 cough64 54 Frequent (79-30%) HP:0012735
18 myocarditis64 54 Frequent (79-30%) HP:0012819
19 autoimmune antibody positivity64 54 Frequent (79-30%) HP:0030057
20 periorbital edema64 54 Frequent (79-30%) HP:0100539
21 congestive heart failure64 54 Occasional (29-5%) HP:0001635
22 aganglionic megacolon64 54 Occasional (29-5%) HP:0002251
23 achalasia64 54 Occasional (29-5%) HP:0002571
24 abnormal large intestine physiology64 54 Occasional (29-5%) HP:0012700
25 abnormality of the nervous system54 Very rare (<4-1%)
26 encephalitis64 54 Very rare (<4-1%) HP:0002383
27 peripheral neuropathy64 54 Very rare (<4-1%) HP:0009830

UMLS symptoms related to Chagas Disease:


fever, pruritus

GenomeRNAi Phenotypes related to Chagas Disease according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00250-A-17.7CXCL8, IL10, IL1B, IL2, NOS2, TGFB1

MGI Mouse Phenotypes related to Chagas Disease according to GeneCards Suite gene sharing:

41 (show all 22)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053829.1CYP51A1, IFNG, IL10, IL12B, NOS2, SMAD2
2MP:00053758.6ADRB1, IL6, NOS2, TGFB1, TLR2, TLR4
3MP:00053898.5CCR5, IFNG, IL10, IL2, IL6, NOS2
4MP:00053918.4CCR5, IFNG, IL10, IL2, IL6, NOS2
5MP:00107718.4IFNG, IL10, IL1B, IL6, NOS2, SMAD2
6MP:00030128.3ADRB1, CCR5, CYP51A1, IFNG, IL10, IL2
7MP:00053868.2CCR5, IFNG, IL10, IL2, IL6, NOS2
8MP:00053798.2ADRB1, IFNG, IL10, IL2, IL6, NOS2
9MP:00053888.2IFNG, IL10, IL12B, IL2, IL6, NOS2
10MP:00053707.9CCR5, IFNG, IL10, IL2, IL6, NOS2
11MP:00020067.9CCR5, IFNG, IL10, IL12B, IL1B, IL2
12MP:00053847.8CALR, CCR5, IFNG, IL10, IL2, IL6
13MP:00053697.6ADRB1, CALR, CCR5, CYP51A1, IFNG, IL10
14MP:00053907.5ADRB1, CYP51A1, IFNG, IL10, IL12B, IL1B
15MP:00053817.5CCR5, CYP51A1, IFNG, IL10, IL12B, IL2
16MP:00053977.4CCR5, IFNG, IL10, IL12B, IL1B, IL2
17MP:00053787.4ADRB1, CALR, CYP51A1, IFNG, IL10, IL2
18MP:00036317.2CALR, CCR5, IFNG, IL10, IL1B, IL6
19MP:00053877.2CCL2, CCR5, CYP51A1, IFNG, IL10, IL12B
20MP:00053856.8ADRB1, CALR, CCR5, CYP51A1, IFNG, IL10
21MP:00053766.6ADRB1, CALR, CCR5, CYP51A1, IFNG, IL10
22MP:00107686.5ADRB1, CALR, CCR5, CYP51A1, IFNG, IL10

Drugs & Therapeutics for Chagas Disease

About this section

Drugs for Chagas Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 176)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
RifampinapprovedPhase 4, Phase 3, Phase 234813292-46-15458213, 5381226
Synonyms:
1-b]furan-21-yl acetate
13292-46-1
3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
3-(4-Methylpiperazinyliminomethyl)-rifamycin SV
3-(4-Methylpiperazinyliminomethyl)rifamycin SV
3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV
3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV
3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin
46713_FLUKA
46713_RIEDEL
62534-43-4
8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
8-(4-Methylpiperazinyliminomethyl) rifamycin SV
8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin
8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv
8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv
83907_FLUKA
83907_SIGMA
8CI)
AZT + Rifampin
Abrifam
Archidyn
Arficin
Arzide
BA-41166E
BIDD:PXR0014
BPBio1_000561
BSPBio_000509
Ba 41166
Ba 41166/E
Benemicin
Benemycin
Bio-0621
C06688
C43H58N4O12
CAS-13292-46-1
CCRIS 551
CHEBI:28077
CHEBI:455936
CHEMBL180
CID5381226
CID5388984
CID5458213
CID5702112
CID6604339
CID6708473
CID6842115
CID6912767
CID6913622
CPD001906767
D00211
DB01045
DRG-0109
Dione 21-acetate
Dipicin
DivK1c_000550
Doloresum
EINECS 236-312-0
Eremfat
Famcin
Fenampicin
HMS1569J11
HMS1920P08
HMS2089F12
HMS2092G09
HMS501L12
HSDB 3181
KBio1_000550
KBio2_000919
KBio2_003487
KBio2_006055
KBio3_003018
KBioGR_001780
KBioSS_000919
L-5103
L-5103 Lepetit
LS-7689
MLS000028552
MLS001148237
MLS001333745
MolPort-000-767-051
MolPort-002-513-586
MolPort-003-666-281
MolPort-006-395-891
NCGC00016699-01
NCGC00017365-01
NCGC00018178-01
NCGC00022678-03
NCGC00022678-04
NCGC00022678-05
NCGC00160500-01
 
NCI60_000309
NINDS_000550
NSC 113926
NSC-113926
NSC113926
Piperine & Rifampicin
Prestwick0_000525
Prestwick1_000525
Prestwick2_000525
Prestwick3_000525
Prestwick_833
R-Cin
R/AMP
R0079
R3501_SIAL
R3501_SIGMA
R5777_SIGMA
R7382_SIGMA
RAMP
RFP
RMP
Ramp
Reserpine & Rifampicin
Rf
Rfamipicin
Rifa
Rifadin
Rifadin (TN)
Rifadin I.V
Rifadin I.V.
Rifadin IV
Rifadin Iv
Rifadin, Rimactane, Rifampicin, Rifampin
Rifadine
Rifagen
Rifaldazin
Rifaldazine
Rifaldin
Rifam
Rifamicin AMP
Rifamor
Rifampicin
Rifampicin & EEP
Rifampicin & Propolis
Rifampicin (JP15/INN)
Rifampicin SV
Rifampicin [INN:BAN:JAN]
Rifampicina
Rifampicina [INN-Spanish]
Rifampicine
Rifampicine [French]
Rifampicinum
Rifampicinum [INN-Latin]
Rifampin
Rifampin (USP)
Rifampin [USAN]
Rifamsolin
Rifamycin
Rifamycin AMP
Rifamycin Amp
Rifaprodin
Rifcin
Rifinah
Rifobac
Rifoldin
Rifoldine
Riforal
Rimactan
Rimactane
Rimactane (TN)
Rimactazid
Rimactin
Rimactizid
Rimazid
Rimycin
Rofact
S1764_Selleck
SAM002264646
SMR000058322
SMR000653525
SPBio_002430
SPECTRUM1500529
STK080143
Sinerdol
Spectrum3_001837
Spectrum4_001250
Spectrum5_002018
Spectrum_000439
TNP00313
Tubocin
UNII-VJT6J7R4TR
WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1
nchembio884-comp4
rifampin
2
Ritonavirapproved, investigationalPhase 4, Phase 2, Phase 3883155213-67-5392622
Synonyms:
1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
155213-67-5
1hxw
1sh9
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
538, ABT
A-84538
ABBOTT-84538
ABT 538
ABT 84538
ABT-538
ABT538
AC-733
AC1L94GB
AKOS000280930
Abbott 84538
BIDD:GT0387
BIDD:PXR0023
Bio-0093
C07240
C37H48N6O5S2
CHEBI:45409
CHEMBL163
CID392622
CPD000466395
D00427
D019438
 
DB00503
DRG-0244
FT-0082824
HMS2051B08
HSDB 7160
LS-148860
MLS000759541
MLS001424063
MolPort-000-883-877
N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide
NCGC00159462-02
NSC693184
Norvir
Norvir (TM)
Norvir (TN)
Norvir Sec
RIT
RTV
Ritonavir
Ritonavir (JAN/USAN/INN)
Ritonavir [USAN]
Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS.
Ritonavirum
S1185_Selleck
SAM001246783
SMR000466395
STK634209
ZINC03944422
ritonavir
3
LopinavirapprovedPhase 4, Phase 2, Phase 3344192725-17-092727
Synonyms:
(1S-(1R*(R*),3R*,4R*))-N-(4-(((2,6-Dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
(2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide
(alphaS)-Tetrahydro-N-((alphaS)-alpha-((2S,3S)-2-hydroxy-4-phenyl-3-(2-(2,6-xylyloxy)acetamido)butyl)phenethyl)-alpha-isopropyl-2-oxo-1(2H)-pyrimidineacetamide
1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)- (9CI)
192725-17-0
1mui
2o4s
2q5k
2rkf
2rkg
A 157378
A 157378.0
A-157378-0
A-157378.0
AB1
ABT 157378
ABT 378
ABT-378
ABT-378, LOPINAVIR
AC1L3OPJ
AIDS032937
 
Aluviran
C12871
C37H48N4O5
CHEBI:40456
CHEMBL729
CID92727
D01425
DB01601
Koletra
LPV
LS-173766
Lopinavir
Lopinavir (JAN/USAN/INN)
Lopinavir [USAN:INN:BAN]
MolPort-003-848-410
N-(4-(((2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pydrimidineacetamide
N-{1-BENZYL-4-[2-(2,6-DIMETHYL-PHENOXY)-ACETYLAMINO]-3-HYDROXY-5-PHENYL-PENTYL}-3-METHYL-2-(2-OXO-TETRAHYDRO-PYRIMIDIN-1-YL)-BUTYRAMIDE
NCGC00164576-01
NCGC00164576-02
RS-346
S1380_Selleck
UNII-2494G1JF75
4
Efavirenzapproved, investigationalPhase 4, Phase 3, Phase 2409154598-52-464139
Synonyms:
(-)-6-CHLORO-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
(-)-Efavirenz
(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(4S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
(4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-ben
(S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
(S)-6-chloro-4-(Cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(S)-6-chloro-4-Cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[D][1,3]oxazin-2-one
154598-52-4
1ikv
1ikw
2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)- (9
6-chloro-4-(2-Cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[D][1,3]oxazin-2-one
6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one
AC-19049
AC1L20IX
BIDD:GT0383
C08088
C14H9ClF3NO2
CHEBI:119486
CHEMBL223228
CID64139
CPD000466351
D00896
DB00625
DB07709
DMP 266
DMP-266
EFV
 
EFZ
Efavirenz
Efavirenz (JAN/INN)
Efavirenzum
Eravirenz
HMS2051J08
HMS2090N16
HSDB 7163
L 743726
L-741211
L-743,726
L-743725
L-743726
LS-173464
MLS000759465
MLS001424087
Met-SDF-1.beta. & Efavirenz
Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz
MolPort-003-983-924
NSC742403
SAM001246667
SBB066062
SMR000466351
Stocrin
Strocin (TM)
Sustiva
Sustiva (TM)
Sustiva (TN)
UNII-JE6H2O27P8
ZINC02020233
efavirenz
efavirenz, (S)-isomer
zoxazin-2-one
Éfavirenz
5
WarfarinapprovedPhase 447081-81-26691, 54678486
Synonyms:
(-)-Warfarin
(S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone
(S)-Warfarin
(phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarin
(phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarine
1-(4'-Hydroxy-3'-coumarinyl)-1-phenyl-3-butanone
200 Coumarin
200 coumarin
3-(1'-Phenyl-2'-acetylethyl)-4-hydroxycoumarin
3-(Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Phenyl-beta-acetylaethyl)-4-hydroxycumarin
3-(alpha-Phenyl-beta-acetylethyl)-4-hydroxycoumarin
4-Hydroxy-3- (3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3- (3-oxo-1-phenyl-butyl)-cumarin
4-Hydroxy-3-(3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-cumarin
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin
4-Idrossi-3- (3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-1-fenil-butil)-cumarine
45706_FLUKA
45706_RIEDEL
4oh-coumarin deriv.
5543-56-6
5543-57-7
81-81-2
A2250_FLUKA
A2250_SIGMA
AC-15978
AC1L1N37
AC1Q6AN3
AR-1E2310
Arab Rat Death
Arab rat death
Arab rat deth
Athrombin
Athrombin-K
Athrombin-k
Athrombine-K
Athrombine-k
BRD-A24514565-001-02-2
BRD-A24514565-236-01-6
BRN 1293536
BSPBio_002026
Bio-0586
Brumolin
C01541
C19H16O4
CBDivE_002127
CBDivE_013236
CBKinase1_000192
CBKinase1_012592
CHEBI:10033
CHEMBL1464
CID6691
CO-Rax
Caswell No. 903
Choice
Choice (TN)
Co-Rax
Co-rax
Compound 42
Coumadin
Coumadin Tabs
Coumafen
Coumafene
Coumafene [French]
Coumaphen
Coumaphene
Coumarins
Coumefene
Cov-R-Tox
Cov-R-tox
D-Con
D08682
DB00682
DL-3-(alpha-acetonylbenzyl)-4-hydroxycoumarin
Dethmor
Dethnel
Dicusat E
Dicusat e
DivK1c_000444
EINECS 201-377-6
EINECS 226-907-3
EPA Pesticide Chemical Code 086002
Eastern states duocide
Fasco fascrat powder
Frass-Ratron
Frass-ratron
HMS1921K07
HMS2092C20
HMS501G06
HSDB 1786
I14-0958
IDI1_000444
Jantoven
KBio1_000444
KBio2_000674
KBio2_003242
KBio2_005810
KBio3_001526
KBioGR_000901
KBioSS_000674
Killgerm sewarin p
Kumader
Kumadu
Kumatox
Kypfarin
LS-55083
Latka 42
Latka 42 [Czech]
Liqua-tox
MLS001304042
Maag Rattentod Cum
Maag rattentod cum
Mar-Frin
Mar-frin
Marevan
Martin'S mar-frin
Martin's mar-frin
 
Maveran
MolPort-001-787-822
Mouse pak
NCGC00094810-01
NCGC00094810-02
NCGC00159398-03
NCGC00178855-01
NINDS_000444
NSC 59813
NSC59813
PS104_SUPELCO
Panwarfin
Place-Pax
Place-pax
Prothromadin
RAX
RCR grey squirrel killer concentrate
RCRA waste no. P001
Rat & mice bait
Rat and mice bait
Rat-B-gon
Rat-Gard
Rat-Kill
Rat-Mix
Rat-O-cide #2
Rat-O-cide no. 2
Rat-Ola
Rat-Trol
Rat-a-way
Rat-alpha-way
Rat-b-gon
Rat-beta-gon
Rat-gard
Rat-kill
Rat-mix
Rat-o-cide #2
Rat-ola
Rat-trol
Ratorex
Ratox
Ratoxin
Ratron
Ratron G
Ratron g
Rats-no-more
Ratten-Koederrohr
Ratten-koederrohr
Rattenstreupulver Neu Schacht
Rattenstreupulver neu schacht
Rattenstreupulver new schacht
Rattentraenke
Rattunal
Rcra waste number P001
Ro-Deth
Ro-deth
Rodafarin
Rodafarin C
Rodafarin c
Rodex
Rodex blox
Rosex
Rough & ready mouse mix
Rough and ready mouse mix
SMP1_000316
SMR000718754
SPBio_000870
SPECTRUM1500613
STK364490
Sakarat
Sewarin
Sofarin
Solfarin
Sorexa Plus
Sorexa plus
Spectrum2_000935
Spectrum3_000583
Spectrum4_000381
Spectrum5_001751
Spectrum_000194
Spray-trol brand roden-trol
Temus W
Temus w
Tintorane
Tox-Hid
Tox-hid
Twin light rat away
UNII-5Q7ZVV76EI
Vampirinip II
Vampirinip III
Vampirinip iii
W.A.R.F. 42
WARF compound 42
WLN: T66 BOVJ DYR&1V1 EQ
Waran
Warf 10
Warf 42
Warfarat
Warfarin (INN)
Warfarin (and salts of)
Warfarin Plus
Warfarin Q
Warfarin [BSI:ISO]
Warfarin [INN:BAN]
Warfarin plus
Warfarin plus [discontinued]
Warfarin sodium
Warfarin titrated to an INR of 2.5-3.0
Warfarin(R)
Warfarina
Warfarina [INN-Spanish]
Warfarine
Warfarine [INN-French]
Warfarine [ISO-French]
Warfarinum
Warfarinum [INN-Latin]
Warficide
Warfilone
Zoocoumarin
Zoocoumarin [Netherlands and USSR]
Zoocoumarin [Russian]
delta-Con
nchembio.307-comp19
rac-Warfarin
warfarin
6
Emtricitabineapproved, investigationalPhase 4, Phase 3457143491-57-060877
Synonyms:
(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(-)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(-)-.beta.-L-FTC
(-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine
(-)-2'-Deoxy-5-fluoro-3'-thiacytidine
(-)-FTC
(-)-beta-2',3'-Dideoxy-5-fluoro-3'-thiacytidine
(-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine
(-)-cis-4-amino-5-Fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
(-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
(2R-cis)-4-Amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
(2R-cis)-4-amino-5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
.beta.-L-(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine
143491-54-7
143491-57-0
145213-48-5
2',3',5-FTC
2',3'-Dideoxy-5-fluoro-3'-thiacytidine
2'-Deoxy-5-fluoro-3'-oxa-4'-thiocytidine
2'-Deoxy-5-fluoro-3'-thiacytidine
2-FTC
3'-Thia-2'.3'-dideoxy-5-fluorocytidine
4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one
4-Amino-5-fluoro-1-[(2R,5S)-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
4-amino-5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)[1,3]oxathiolan-5-yl]cytosine
524W91
AC1L1U3I
AC1Q4KUB
BW 1592
 
BW 524W91
BW-524W91
BW524W91
C122114
C12599
C8H10FN3O3S
CHEBI:31536
CHEMBL885
CID60877
Coviracil
Coviracil(TM)
D01199
DB00879
DRG-0208
Emtricitabin
Emtricitabina
Emtricitabine
Emtricitabine (JAN/USAN/INN)
Emtricitabinum
Emtriva
Emtriva (TN)
Emtriva(TM)
FT-0080009
HMS2089I05
HSDB 7337
LS-135838
LS-173184
NCGC00164564-01
RCV
Racivir
SBB066061
TL8000958
UNII-G70B4ETF4S
ZINC03629271
beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine
dOTFC
emtricitabine
7
EthambutolapprovedPhase 4, Phase 3, Phase 28474-55-53279, 14052
Synonyms:
(+)-(S,S)-2,2'-(1,2-Ethylenediimino)-di-1-butanol
(+)-2,2'-(Ethylenediimino)di-1-butanol
(+)-2,2'-(ethylenediimino)di-1-butanol
(+)-N,N'-Bis(1-(hydroxymethyl)propyl)ethylenediamine
(+)-N,N'-bis(1-(hydroxymethyl)propyl)ethylenediamine
(+)-S,S-Ethambutol
(+)-S,S-ethambutol
(+)-ethambutol
(-)-(R,R)-2,2'-(1,2-Ethylenediimino)-di-1-butanol
(2'S)-2,2'-[Ethane-1,2-diyldi(imino)]dibutan-1-ol
(2R)-2-[2-(1-hydroxybutan-2-ylamino)ethylamino]butan-1-ol
(2R)-2-[2-[[(2R)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol
(2S)-2-[2-(1-hydroxybutan-2-ylamino)ethylamino]butan-1-ol
(2S)-2-[2-[[(2R)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol
(2S)-2-[2-[[(2S)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol
(2S,2'S)-2,2'-(ethane-1,2-diyldiimino)dibutan-1-ol
(2S,7S)-2,7-Diethyl-3,6-diazaoctane-1,8-diol
(2S,7S)-2,7-diethyl-3,6-diazaoctane-1,8-diol
(R)-2,2'-(1,2-Ethanediyldiimino)bis-1-butanol
(S,R)-2,2'-(1,2-Ethylenediimino)-di-1-butanol
(S,S)-Ethambutol
(S,S)-ethambutol
1070-11-7
2,2'-(1,2-Ethylenediimino)-di-1-butanol
2,2'-(ethane-1,2-diyldiimino)dibutan-1-ol
2-[2-(1-hydroxybutan-2-ylamino)ethylamino]butan-1-ol
74-55-5
75343-56-5
AC1L1FKQ
AC1L230T
AC1L9YT2
AC1LABPH
AC1LAKIP
AC1LAKIS
AC1Q2C85
AC1Q2SHV
AC1Q77PZ
AR-1A7805
AR-1C2065
Aethambutolum
BPBio1_000105
BSPBio_000095
BSPBio_002012
C06984
C10H24N2O2
CAS-1070-11-7
CHEBI:4877
CHEMBL43824
CHEMBL44884
CID14052
CID3279
CID465436
CID470071
CID470072
CID504259
CL 40881 (dihydrochloride)
CPD000046147
D-2,2'-(Ethylenediimino)bis(1-butanol)
D-2,2'-(Ethylenediimino)di-1-butanol
D-Ethambutol
D-N,N'-Bis(1-hydroxymethylpropyl)ethylenediamine
D07925
DB00330
Dadibutol
Diambutol
 
DivK1c_000561
EINECS 200-810-6
EMB
Etambutol
Etambutol [INN-Spanish]
Etambutolo
Etambutolo [DCIT]
Ethambutol
Ethambutol & EEP
Ethambutol & Propolis
Ethambutol (INN)
Ethambutol HCL
Ethambutol Hydrochloride
Ethambutol [INN:BAN]
Ethambutol dihydrochloride
Ethambutol, (-)-isomer
Ethambutol, meso form
Ethambutol, racemic mixture
Ethambutolum
Ethambutolum [INN-Latin]
Etibi
HSDB 3078
IDI1_000561
KBio1_000561
KBio2_001538
KBio2_004106
KBio2_006674
KBio3_001232
KBioGR_001209
KBioSS_001538
KST-1A8084
LS-187119
LS-46537
MLS000082702
Miambutol
MolPort-002-507-956
MolPort-003-847-110
Myambutol
Myambutol (dihydrochloride)
NCGC00016560-01
NCGC00178864-01
NCGC00179661-01
NINDS_000561
NSC653313
Prestwick0_000028
Prestwick1_000028
Prestwick2_000028
Prestwick3_000028
Purderal
S,S-Ethambutol
SAM002589988
SMR000046147
SPBio_001167
SPBio_002016
STK711105
STOCK5S-98432
Servambutol
Servambutol (TN)
Spectrum2_001014
Spectrum3_000426
Spectrum4_000545
Spectrum5_000702
Spectrum_001058
Tibutol
UNII-8G167061QZ
d,N,N'-Bis(1-hydroxymethylpropyl)ethylenediamine
ethambutol
8
Lamivudineapproved, investigationalPhase 4, Phase 3, Phase 2621134678-17-460825
Synonyms:
(+/-) (Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(+/-)-3TC
(+/-)-BCH-189
(+/-)-SddC
(-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine
(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
(-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(-)-2'-Deoxy-3'-thiacytidine
(-)-BCH 189
(-)-BCH-189
(-)-SddC
(-)-beta-L-2',3'-Dideoxy-3'-thiacytidine
(-)NGPB-21
(2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
.beta.-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To
134678-17-4
2',3' Dideoxy 3' thiacytidine
2',3'-Dideoxy-3'-thiacytidine
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-) (Cis)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Galanthus Nivalis Agglutinin (GNA)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Hippeastrum hybrid agglutinin( HHA)
3'-Thia-2',3'-dideoxycytidine
3TC
3TC & GNA
3TC & SST
3TC (AIDS INITIATIVE) (AIDS INITIATIVE)
3TC and NV-01
3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine
4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
480434-79-5
AC-1416
AC1L1TZZ
AC1Q6C34
BCH 189
BCH-189
BCH-790
BCH189
BIDD:GT0033
Bio-0652
C07065
C8H11N3O3S
CCRIS 9274
CHEBI:133986
CHEMBL141
CID60825
CPD000466319
D00353
D019259
 
DB00709
DRG-0126
DTHC
Epivir
Epivir (TN)
Epivir(TM)
Epivir-HBV
Epzicom
FT-0082667
GG-714
GR 109714X
GR-109714X
GR109714X
HHA & 3TC
HHA & Lamivudine
HMS2051D21
HSDB 7155
Hepitec
Heptivir
Heptodin
Heptovir
L0217
LMV
LS-2107
Lamivir
Lamivudin
Lamivudina
Lamivudine
Lamivudine & GNA
Lamivudine (JAN/USP/INN)
Lamivudine [USAN:BAN:INN]
Lamivudine [USAN:INN:BAN]
Lamivudine [Usan:Ban:Inn]
Lamivudine, (2S-cis)-Isomer
Lamivudinum
MLS000759424
MLS001424097
MolPort-002-507-347
NCGC00159341-03
NCGC00159341-04
NSC620753
S1706_Selleck
SAM001246582
SAM002589994
SMR000466319
STK801940
UNII-2T8Q726O95
ZINC00012346
Zeffix
Zefix
beta-L-2',3'-Dideoxy-3'-thiacytidine
beta-L-3'-Thia-2',3'-dideoxycytidine
lamivudine
9
ZidovudineapprovedPhase 4, Phase 3, Phase 249530516-87-135370
Synonyms:
-Azido-3&prime
-deoxythymidine
1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine
3&prime
3' Azido 2',3' Dideoxythymidine
3' Azido 3' deoxythymidine
3'-Azido-2',3'-Dideoxythymidine
3'-Azido-3'-deoxythymidine
3'-Azido-3'-deoxythymidine & Concanavalin A
3'-Azido-3'-deoxythymidine & Erythropoietin
3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19
3'-Azido-3'-deoxythymidine & Interleukin-1
3'-Azido-3'-deoxythymidine & Interleukin-2
3'-Azido-3'-deoxythymidine & Interleukin-6
3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin
3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1
3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6
3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon
3'-Azido-3'-deoxythymidine & Sho-Saiko-To
3'-Azido-3'-deoxythymidine (AIDS)
3'-Azido-3'deoxythymidine & Interferon .alpha.
3'-Azidothymidine
3'-Deoxy-3'-azidothymidine
3'-azido-3'-deoxythymidine, AZT
3-Azido-3-deoxythymidine
30516-87-1
399024-19-2
A2169_SIGMA
AC1L1TKL
AC1Q2OEK
AZT
AZT & CD4(178)-PE 40
AZT & Colony-stimulating factor 2
AZT & Concanavalin A (ConA)
AZT & EPO
AZT & GM-CSF
AZT & HPA
AZT & IFN.alpha.
AZT & IL-1
AZT & IL-2
AZT & IL-6
AZT & Interferon-.alpha.-2
AZT & Li & EPO
AZT & Li & GM-CSF
AZT & Li & IL-1
AZT & Li & IL-6
AZT & Lymphoblastoid Interferon
AZT & NP (from PHCA or HSA)
AZT & PM-19
AZT & SST
AZT & rIFN.alpha.2
AZT & rsCD4 & rIFN.alpha.A
AZT & rsT4
AZT & sCD4
AZT & srCD4
AZT (Antiviral)
AZT Antiviral
AZT TRANSPLACENTAL CARCINOGENESIS STUDY
AZT+PRO 140
AZT, Antiviral
Antiviral AZT
Apo-Zidovudine
Azidothymidine
Aztec
BB_NC-1012
BPBio1_000403
BRD-K72903603-001-04-6
BSPBio_000365
BSPBio_003153
BW A509U
BW-A 509U
BW-A-509U
BW-A509U
BWA 509U
BWA-509U
BWA509U
C07210
CCRIS 105
CHEBI:10110
CHEBI:127307
CHEMBL129
CID35370
 
CPD000058351
Compound S
Cpd S
D00413
D015215
DB00495
DRG-0004
DS-4152 & AZT
DivK1c_000524
HMS1921J20
HMS2090G11
HMS2092D06
HMS501K06
HSDB 6515
IDI1_000524
Interferon AD + 3'-azido-3'-deoxythymidine
Intron A & AZT
K7 [P Ti2 W10 O40]
KBio1_000524
KBio2_001828
KBio2_004396
KBio2_006964
KBio3_002653
KBioGR_000703
KBioSS_001828
LS-1159
Liposomal AZT-SN-1
Liposomal AZT-SN-3
MLS000028548
MLS001055351
MLS001076358
MLS002153202
MLS002222249
Met-SDF-1.beta. & AZT
Met-SDF-1.beta. & Zidovudine
MolPort-002-507-286
NCGC00023945-03
NCGC00023945-04
NCGC00023945-05
NCGC00023945-08
NCGC00178237-01
NCGC00178237-02
NINDS_000524
NSC 602670
Novo-Azt
PC-SOD+AZT
Prestwick3_000333
Propolis+AZT
Racemic Liposomal AZT
Retrovir
Retrovir (TN)
Retrovir(TM)
SAM002548971
SMR000058351
SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle)
SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle)
SPBio_000834
SPECTRUM1502109
STK801891
Spectrum2_000927
Spectrum3_001507
Spectrum4_000332
Spectrum5_001101
Spectrum_001348
UNII-4B9XT59T7S
ZDV
ZIDOVUDINE [AZT]
ZINC03779042
ZVD
Zidovudin
Zidovudina
Zidovudina [Spanish]
Zidovudine (JAN/USP/INN)
Zidovudine EP III
Zidovudine [USAN:INN:BAN:JAN]
Zidovudine+PRO 140
Zidovudinum
Zidovudinum [Latin]
antiviral
azidodeoxythymidine
rIFN-beta seron & AZT
racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle)
zidovudin
zidovudine
10
DidanosineapprovedPhase 4, Phase 315069655-05-650599
Synonyms:
149409-57-4
2',3'-Dideoxyinosine
2',3'-Dideoxyinosine & Granulocyte-macrophage colony-stimulating factor
2',3'-Dideoxyinosine & Interferon-.alpha.
2',3'-Dideoxyinosine & sCD4(soluble recombinant protein)
2',3'-Dideoxyinosine (AIDS Initiative)
2',3'-Dideoxyinosine (ddI)
2',3'-dideoxyinosine, DDI, NSC 612049, Didanosine
2'3'-DIDEOXYINOSINE
2,3-Dideoxyinosine
2,3-dideoxyinosine
2DI
3'-Azido-3'-deoxythymidine + 2',3'-Dideoxyinosine
69655-05-6
9-((2R,5S)-5-(Hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purin-6(9H)-one
9-((2R,5S)-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purin-6(9H)-one
9-((2R,5S)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one
9-((2S,5R)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-ol
9-(2,3-Dideoxy-beta-D-ribofuranosyl)-6-oxopurine
9-(2,3-Dideoxy-beta-D-ribofuranosyl)hypoxanthine
9-[(2R,5R)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL]-1,9-DIHYDRO-6H-PURIN-6-ONE
9-[(2R,5S)-5-(Hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one
9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one
9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one
AC-12026
AC1L19ET
AC1L3OPK
BMY 40900
BMY-40900
BRN 3619529
Benzeneethanamine, 4-methoxy-3-(2-phenylethoxy)-N,N-dipropyl-, hydrochloride
Bio-0685
C06953
C083832
CCRIS 805
CHEBI:490877
CHEMBL1460
CID119381
CID50599
CPD000058576
D00296
D2I
D3066
DB00900
DB02392
DDI
DDI and rIFN.alpha.2
DIDEOXYINOSINE
DRG-0016
DS-4152 & ddI
DdIno
Didanosina
 
Didanosina [INN-Spanish]
Didanosine
Didanosine (JAN/USAN/INN)
Didanosine and Interferon-.alpha.-2
Didanosinum
Didanosinum [INN-Latin]
Dideoxyinosine
Dideoxyinosine (DDI)
FT-0082664
HMS2051J11
HMS2089N20
HSDB 6548
Hypoxanthine ddN
Inosine, 2',3'-dideoxy- & Recombinant Interferon-.alpha.-2
Intron A & Videx
KS-1049
LOA & ddI
Listera ovata agglutinin & 2',3'-Dideoxyinosine
MLS000759469
MLS001055350
MLS001424118
MLS002154216
MolPort-002-507-371
MolPort-002-885-819
N,N-Dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride
N,N-diethyl-2-(4-methoxy-3-phenethyloxyphenyl)ethanamine hydrochloride
NCGC00090691-01
NCGC00159514-02
NCGC00159514-03
NCGC00164280-01
NE 100
NE-100
NSC 612049
NSC-612049
NSC612049
PC-SOD+ddI
S1702_Selleck
SAM001246673
SMR000058576
Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine
UNII-K3GDH6OH08
Videx
Videx (TN)
Videx EC
Videx EC(TM)(slow-release capsules)
Videx(TM)
ZINC13597823
ddI & GM-CSF
ddI & IFN-.alpha.
ddI & sCD4(rsCD4)
ddI + d4T combination
ddIno
didanosine
11
PyrazinamideapprovedPhase 4, Phase 3, Phase 29098-96-41046
Synonyms:
2-Carbamylpyrazine
2-Pyrazinecarboxamide
2-carbamyl pyrazine
2-carbamylpyrazine
2-pyrazinecarboxamide
5-25-04-00178 (Beilstein Handbook Reference)
82612_FLUKA
98-96-4
AB00052083
AC-907/25014068
AC1L1ALT
AC1Q4ZGM
AKOS000120280
AZT + Pyrazinamide combination
Aldinamid
Aldinamide
BB_SC-1250
BIDD:GT0228
BPBio1_000515
BRN 0112306
BSPBio_000467
BSPBio_002572
Braccopiral
C01956
C5H5N3O
CAS- 98-96-4
CCRIS 545
CHEBI:45285
CHEMBL614
CID1046
CPD000036662
Corsazinmid
D-50
D-50 (VAN)
D00144
D011718
DB00339
DRG 0124
Dipimide
DivK1c_000241
EINECS 202-717-6
EU-0101011
Eprazin
Farmizina
HMS1569H09
HMS1920N08
HMS2092E09
HMS500M03
HSDB 3576
I14-6758
IDI1_000241
InChI=1/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9
Isopas
KBio1_000241
KBio2_001382
KBio2_003950
KBio2_006518
KBio3_001792
KBioGR_001851
KBioSS_001382
LS-2053
Lopac-P-7136
Lopac0_001011
Lynamide
MK 56
MLS000069730
MLS002222347
MolPort-001-770-770
NCGC00015833-01
NCGC00015833-02
NCGC00015833-05
NCGC00015833-10
NCGC00090695-01
NCGC00090695-03
NCGC00090695-04
NCGC00090695-05
NCGC00090695-06
 
NCGC00090695-07
NCI-C01785
NINDS_000241
NSC 14911
NSC14911
Novamid
P 7136
P ezetamid
P0633
P7136_SIGMA
PZA
Pezetamid
Pharozinamide
Piraldina
Pirazimida
Pirazinamid
Pirazinamida
Pirazinamida [INN-Spanish]
Pirazinamide
Pirazinamide [DCIT]
Pirilene
Prazina
Prestwick0_000514
Prestwick1_000514
Prestwick2_000514
Prestwick3_000514
Prestwick_811
Pyrafat
Pyramide
Pyrazide
Pyrazinamdie
Pyrazinamid
Pyrazinamida
Pyrazinamide
Pyrazinamide (JP15/USP/INN)
Pyrazinamide (TN)
Pyrazinamide BP 2000
Pyrazinamide [INN:BAN:JAN]
Pyrazinamidum
Pyrazinamidum [INN-Latin]
Pyrazine carboxamide
Pyrazine carboxylamide
Pyrazineamide
Pyrazinecarboxamide
Pyrazinecarboxylic acid amide
Pyrazinoic acid am ide
Pyrazinoic acid amide
Pyrazinoic acid amide, Pezetamid, Pyrafat, Zinamide, Tebrazid, Pyrafat, Pyrazinamide
Pyrizinamide
Rifater
Rozide
S1762_Selleck
SAM002554927
SMR000036662
SPBio_001369
SPBio_002388
SPECTRUM1500518
STK801661
Spectrum2_001305
Spectrum3_001046
Spectrum4_001186
Spectrum5_001026
Spectrum_000902
T 165
Tebrazid
Tebrazio
Tisamid
UNII-2KNI5N06TI
Unipyranamide
WLN: T6N DNJ BVZ
ZINC00002005
Zinamide
Zinastat
pms-Pyrazinamide
pyrazinamide
pyrazine carboxylamide
pyrazine-2-carboxamide
pyrazinecarboxamide
pyrazinoic acid amide
12
IsoniazidapprovedPhase 4, Phase 3, Phase 215554-85-33767
Synonyms:
37271-10-6
4-pyridinecarbohydrazide
41466-07-3
5015 R.P
5015 R.P.
5015 RP
54-85-3
62229-51-0
7640-37-1
AB00052025
AC1L1GNZ
AC1Q54UP
AC1Q54UQ
AI3-23936
AKOS000119062
AZT + Isoniazid
Abdizide
Andrazide
Anidrasona
Antimicina
Antituberkulosum
Armacide
Armazid
Armazide
Atcotibine
Azuren
BB_SC-6246
BIDD:GT0140
BP 5015
BPBio1_000025
BPBio1_001322
BSPBio_000021
BSPBio_002204
Bacillin
Biomol-NT_000288
C07054
C6H7N3O
CAS-54-85-3
CCRIS 351
CHEBI:6030
CHEMBL64
CID3767
CPD000059082
Cedin
Cedin (Aerosol)
Cemidon
Chemiazid
Chemidon
Continazine
Cortinazine
Cotinazin
Cotinizin
D00346
D007538
DB00951
Defonin
Dibutin
Diforin
Dinacrin
Ditubin
DivK1c_000070
Dow-Isoniazid
EINECS 200-214-6
Ebidene
Eralon
Ertuban
Eutizon
Evalon
FRS-3
FSR 3
FSR-3
Fetefu
Fimalene
GINK
HIA
HMS1568B03
HMS1920H09
HMS2089I16
HMS2091N19
HMS500D12
HSDB 1647
Hid rasonil
Hidranizil
Hidrasonil
Hidrulta
Hidrun
Hycozid
Hydra
Hydrazid
Hydrazide
Hyozid
Hyzyd
I.A.I
I.A.I.
I0138
I14-9731
I3377_FLUKA
I3377_SIGMA
IDI1_000070
INH
INHd20
Ido-tebin
Idrazil
In-73
Inah
Inh-Burgthal
Inizid
Iscotin
Isidrina
Ismazide
Isobicina
Isocid
Isocidene
Isocotin
Isohydrazide
Isokin
Isolyn
Isonerit
Isonex
Isoniacid
Isoniazid
Isoniazid & EEP
Isoniazid & Propolis
Isoniazid SA
Isoniazida
Isoniazide
Isoniazidum
Isonicazide
Isonicid
Isonico
Isonicotan
Isonicotil
Isonicotinhydrazid
Isonicotinic acid hydrazide
Isonicotinic hydrazide
Isonicotinohydrazide
Isonicotinoyl hydrazide
Isonicotinoylhydrazide
Isonicotinsaeurehydrazid
Isonicotinyl hydrazide
Isonicotinyl hydrazine
Isonicotinylhydrazine
Isonide
Isonidrin
Isonikazid
Isonilex
Isonin
Isonindon
Isonirit
Isoniton
Isonizida
Isonizide
Isopyrin
 
Isotamine
Isotebe
Isotebezid
Isotinyl
Isozid
Isozide
Isozyd
KBio1_000070
KBio2_001333
KBio2_003901
KBio2_006469
KBio3_001424
KBioGR_000423
KBioSS_001333
L 1945
LANIZID
LS-205
Laniazid
Laniazid (TN)
Laniozid
MLS000069444
MLS001055327
MolPort-000-141-557
Mybasan
NCGC00016244-01
NCGC00016244-02
NCGC00022648-03
NCGC00022648-04
NCGC00022648-05
NCGC00022648-06
NINDS_000070
NSC 9659
NSC9659
Neo-Tizide
Neoteben
Neoxin
Neumandin
Nevin
Niadrin
Nicazide
Nicetal
Nicizina
Niconyl
Nicotibina
Nicotibine
Nicotisan
Nicozide
Nidaton
Nidrazid
Nikozid
Niplen
Nitadon
Niteban
Nitebannsc 9659
Nydrazid
Nyscozid
Oprea1_396155
Pelazid
Percin
Phthisen
Preparation 6424
Prestwick0_000161
Prestwick1_000161
Prestwick2_000161
Prestwick3_000161
Prestwick_578
Pycazide
Pyreazid
Pyricidin
Pyridicin
Pyridine-4-carboxylic acid hydrazide
Pyrizidin
RP 5015
RP-5015
RU-EF-Tb
RY-EF-Tb
Raumanon
Razide
Retozide
Rifamate
Rimicid
Rimifon
Rimiphone
Rimitsid
Robiselin
Robisellin
Roxifen
S1937_Selleck
SAM002554904
SMR000059082
SPBio_000094
SPBio_001942
SPECTRUM1500355
STK086288
Sanohidrazina
Sauterazid
Sauterzid
Spectrum2_000107
Spectrum3_000472
Spectrum4_000022
Spectrum5_000876
Spectrum_000853
Stanozide
TB-Phlogin
TB-Razide
TB-Vis
Tebecid
Tebenic
Tebexin
Tebilon
Tebos
Teebaconin
Tekazin
Tibazide
Tibemid
Tibiazide
Tibinide
Tibison
Tibivis
Tibizide
Tibusan
Tisin
Tisiodrazida
Tizide
Tubazid
Tubazide
Tubeco
Tubecotubercid
Tuberian
Tubicon
Tubilysin
Tubizid
Tubomel
Tyvid
UNII-V83O1VOZ8L
Unicocyde
Unicozyde
Usaf cb-2
Vazadrine
Vederon
WLN: T6NJ DVMZ
ZINC00001590
Zidafimia
Zinadon
Zonazide
bacillen
bp 5 015
isoco tin
isoniazid
isozid e
nchembio884-comp3
nidra zid
rimif on
tebemid
tubercid
13
EnalaprilatapprovedPhase 412476420-72-96917719
Synonyms:
(2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid
(2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid dihydrate
1-((2S)-2-{[(1S)-1-CARBOXY-3-PHENYLPROPYL]AMINO}PROPANOYL)-L-PROLINE
1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate
76420-72-9
AC1NUWEA
AC1OCEK7
BIDD:GT0752
C11720
C18H24N2O5.2H2O
CHEBI:116759
CHEBI:42302
CHEBI:4786
CHEBI:59877
CHEMBL1200697
CHEMBL577
CID5462501
CID6917719
CPD000466359
D03769
EAL
ENALAPRILAT INHIBITOR
Enalapril acid
Enalapril diacid
Enalaprilat
Enalaprilat (USP)
 
Enalaprilat anhydrous
Enalaprilate
Enalaprilatum
Enalaprilic acid
Enalprilate hydrate
HMS2051H16
HMS2089P04
LS-118903
LS-187219
MK-422
MLS000759476
MLS001424138
MolPort-005-943-792
N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl-L-proline
N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline
N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline--water (1/2)
N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline—water (1/2)
NCGC00164593-01
S1657_Selleck
SAM001246684
SBB065733
SMR000466359
Vasotec I.V.
enalaprilat dihydrate
enalaprilat hydrate
enalprilat hydrate
enalprilate hydrate
14
Tenofovirapproved, investigationalPhase 4, Phase 3, Phase 2759147127-20-6464205
Synonyms:
(R)-9-(2-Phosphonomethoxypropyl)adenine
(R)-9-(2-Phosphonylmethoxypropyl)adenine
(R)-9-(2-phosphonomethoxypropyl)adenine
(R)-PMPA
147127-20-6
206184-49-8
AC-760
AC1LA9BO
Anh. tenofovir
Anhydrous tenofovir
Apropovir
CHEBI:45809
CHEMBL483
CID464205
D,L-Tenofovir
DB00300
GNA & Tenofovir
GS 1275
GS 1278
GS1278
 
HHA & Tenofovir
KS-5021
MolPort-003-850-411
NCGC00167535-01
PMPA
PMPA-(R)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Galanthus nivalis agglutinin (GNA)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Hippeastrum hybrid agglutinin( HHA)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- (9CI)
Phosphonic acid, [[2-(6-amino-9H-purin-9
S1401_Selleck
TDF
TFV
Tenefovir
Tenofovir
Tenofovir (anh.)
Tenofovir disoproxil
Tenofovir disoproxil fumarate
UNII-99YXE507IL
Viread
Viread, Tenofovir
[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
15
Enalaprilapproved, vet_approvedPhase 412475847-73-35362032, 40466924
Synonyms:
(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid
(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline
(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid
1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester
75847-73-3
AC1NTUS5
Analapril
BIDD:GT0751
BPBio1_000340
BSPBio_000308
BSPBio_003035
Bonuten
C06977
CAS-76095-16-4
CHEBI:116847
CHEBI:4784
CHEMBL578
CID5388962
D07892
DivK1c_000408
Enalapril
Enalapril (INN)
Enalapril (TN)
Enalapril Bp
Enalapril Maleate
Enalapril Richet
Enalaprila
Enalaprila [INN-Spanish]
Enalaprilat
Enalaprilum
 
Enalaprilum [INN-Latin]
Gadopril
HMS2090E08
IDI1_000408
KBio1_000408
KBio2_001787
KBio2_004355
KBio2_006923
KBio3_002535
KBioGR_000355
KBioSS_001787
Kinfil
LS-190651
MolPort-002-885-877
N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline
N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline
NCGC00016932-01
NCGC00021569-04
NCGC00021569-05
NCGC00021569-06
NINDS_000408
Prestwick3_000314
SPBio_001349
Spectrum2_001455
Spectrum3_001478
Spectrum4_000008
Spectrum5_001107
Spectrum_001307
Vaseretic
Vasotec
Vasotec IV
enalapril
16
Carvedilolapproved, investigationalPhase 416872956-09-32585
Synonyms:
(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol
(+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol
(+-)-1-Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol
(+/-)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol
1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol
1-(9H-carbazol-4-yloxy)-3-[(2-{[2-(methyloxy)phenyl]oxy}ethyl)amino]propan-2-ol
1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol
1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol
107741-96-8
72956-09-3
AB1004830
AC-1641
AC1L1E0B
Artist
Artist (TN)
Atlana Pharma brand of carvedilol
BM 14190
BM-14-190
BM-14.190
BM-14190
BRD-A10977446-001-04-8
BRD-A10977446-045-01-1
Bio-0014
C043211
C06875
C2260
C24H26N2O4
CHEBI:3441
CHEMBL723
CID2585
CPD000449280
Carvedilol
Carvedilol (JAN/USAN/INN)
Carvedilol [USAN:INN:BAN:JAN]
Carvedilolum
Carvedilolum [Latin]
Coreg
Coreg (TN)
Coreg CR
Coropres
Coropress
D00255
DB01136
DQ 2466
DQ-2466
Dibloc
 
Dilatrend
EG-P042
Eucardic
GlaxoSmithKline brand of carvedilol
HMS2051N03
HMS2089B09
HMS2093E12
HSDB 7044
I06-0064
I06-1477
KBio2_002145
KBio2_004713
KBio2_007281
KBio3_002323
KBioGR_001252
KBioSS_002145
Kredex
L001243
LS-121875
Lakeside brand of carvedilol
MLS000758299
MLS000759508
MLS001424092
MolPort-003-666-814
NCGC00167832-01
NCGC00167832-02
NCGC00167832-03
Querto
Roche brand of carvedilol
SAM001246736
SAM001247021
SK&F-105517
SKF 105517
SMR000449280
SPBio_001885
STK621453
Spectrum2_001673
Spectrum3_001182
Spectrum4_000636
Spectrum5_001436
Spectrum_001665
TL8005080
UNII-0K47UL67F2
carvedilol
carvedilol, (+-)-isomer
carvedilol, (R)-isomer
carvedilol, (S)-isomer
carvedilol, 14C-labeled
17
Aspirinapproved, vet_approvedPhase 4115250-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalicylsäure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide acetylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Aloxiprimum
Asacard
Asagran
Asatard
Ascoden-30
Aspalon
Aspec
Aspergum
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin [BAN:JAN]
Aspirina 03
Aspirine
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Aspirin 8 Hour
Bayer Buffered
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Plus
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Bufferin
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ecolen
Ecotrin
Empirin
Empirin with Codeine
Endosprin
Endydol
Entericin
Enterophen
 
Enterosarein
Enterosarine
Entrophen
Extren
Globentyl
Globoid
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Helicon
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Levius
Lopac-A-5376
Lopac0_000038
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medisyl
Micristin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Persistin
Pharmacin
Pirseal
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
Supac
Tasprin
Temperal
Toldex
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
acide 2-(acétyloxy)benzoïque
acide acétylsalicylique
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
salicylic acid acetate
ácido acetilsalicílico
18
DarunavirapprovedPhase 4210635728-49-3, 206361-99-1213039
Synonyms:
(3-((4-aminobenzenesulfonyl)isobutylamino)-1-benzyl-2-hydroxypropyl)carbamic acid hexahydrofuro(2,3-b)furan-3-yl ester
(3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE
(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate
(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate
(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate
(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate
(3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate
(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate
(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate
(3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate
(3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate
206361-99-1
2f80
2f81
2f8g
2hs1
2hs2
2idw
2ien
3bvb
3cyw
3d1z
3d20
618109-00-5
AC1L4U4V
AIDS073035
CHEBI:367163
CHEMBL1323
 
CID213039
Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester
D03656
DB01264
Darunavir
Darunavir (USAN/INN)
Darunavir [USAN]
Darunavirum
Darunavirum [INN-Latin]
Darunavirum [INN-latin]
LS-187026
LS-187772
LS-191295
MolPort-003-846-141
N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide
Prezista
Prezista(TM)
TMC 114
TMC-114
TMC114
UIC 94017
UIC-94017
UIC-96017
UNII-YO603Y8113
[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate
[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester
[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester
{(1S,2R)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester
{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester
19
EtravirineapprovedPhase 474269055-15-4193962
Synonyms:
269055-15-4
394729-17-0
4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)-4-pyrimidinyl)oxy)-3,5-dimethyl-benzonitrile
4-({6-AMINO-5-BROMO-2-[(4-CYANOPHENYL)AMINO]PYRIMIDIN-4-YL}OXY)-3,5-DIMETHYLBENZONITRILE
4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile
65B
AC1L4XC5
CHEBI:213138
CHEMBL308954
CID193962
D04112
DAPY deriv
DB07191
Diaminopyrimidine deriv
Etravirine
 
Etravirine (JAN/USAN/INN)
I06-1887
Intelence
Intelence (TN)
Intelence(TM)
R 165335
R-165335
R165335
R165335-TMC125
ST51053273
TMC 125
TMC-125
TMC-125/R-165335
TMC125
UNII-0C50HW4FO1
ZINC00602632
20
Pyridoxineapproved, nutraceutical, vet_approvedPhase 4, Phase 3, Phase 218865-23-61054
Synonyms:
(5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate
12001-78-4
2-Methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine
2-Methyl-3-hydroxy-4,5-di(hydroxymethyl)pyridine
2-Methyl-3-hydroxy-4,5-dihydroxymethyl-pyridin
2-Methyl-3-hydroxy-4,5-dihydroxymethyl-pyridin [German]
2-Methyl-3-hydroxy-4,5-dihydroxymethylpyridine
2-Methyl-4,5-bis(hydroxymethyl)-3-hydroxypyridine
2-methyl-3-hydroxy-4,5-bis(hydroxy-methyl) pyridine
2-methyl-3-hydroxy-4,5-dihydroxymethylpyridine
2-methyl-4,5-dimethylol-pyridin-3-ol
2B3E07D2-E4CC-4CC5-B085-6070BA01F9F0
3,4-Pyridinedimethanol, 5-hydroxy-6-methyl-, hydrochloride
3-Hydroxy-2-Picoline-4,5-dimethanol
3-Hydroxy-4,5-dihydroxymethyl-2-methylpyridine hydrochloride
3-Hydroxy-4,5-dimethylol-.alpha.-picoline hydrochloride
3-Hydroxy-4,5-dimethylol-alpha-picoline
3-Hydroxy-4,5-dimethylol-alpha-picoline hydrochloride
3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine
4,5-Bis(hydroxymethyl)-2-methyl-3-pyridinol
4,5-Bis(hydroxymethyl)-2-methylpyridin-3-ol hydrochloride
4,5-bis(hydroxymethyl)-2-methyl-3-pyridinol hydrochloride
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol
4,5-bis(hydroxymethyl)-2-methylpyridine-3-ol
4-Deoxypyridoxine 5'-phosphate
47862_SUPELCO
5-Hydroxy-6-methyl-3,4-pyridinedicarbinol hydrochloride
5-Hydroxy-6-methyl-3,4-pyridinedimethanol
5-Hydroxy-6-methyl-3,4-pyridinedimethanol hydrochloride
5-Hydroxy-6-methyl-3,4-pyridinedimethanol, hydrochloride
58-56-0
58-56-0 (HCL)
58-56-0 (hydrochloride)
65-23-6
65-23-6 (Parent)
8059-24-3
85078-23-5
AC-12024
AC-14512
AC-907/25014218
AC1L1AMH
AC1L1LMI
AC1L2XK2
AC1Q22HP
AC1Q2G66
AC1Q3F63
AI3-19016
AIDS-006784
AIDS006784
AR-1A6363
AR-1J1632
Adermin hydrochloride
Adermine
Adermine hydrochloride
Aderomine hydrochloride
Aderoxin
Aderoxine
Alestrol
BB_NC-0050
BIDD:PXR0180
BPBio1_000646
BSPBio_000586
Becilan
Beesix
Benadon
Bonasanit
C00314
C8H11NO3
CAS-58-56-0
CBDivE_015627
CCRIS 1903
CHEBI:16709
CHEBI:30961
CHEMBL1200756
CHEMBL1364
CID104817
CID1054
CID6019
CPD0-1221
Campoviton 6
Cernevit-12
D02179
D025101
D08454
DB00165
EINECS 200-386-2
EINECS 200-603-0
EINECS 232-503-8
Godabion
Gravidox
HMS1569N08
HMS2093L07
HSDB 1212
Hexa-Betalin
Hexa-Betalin (R)
Hexa-betalin (TN)
Hexabetalin
Hexabione hydrochloride
 
Hexavibex
Hexermin
Hexermine
Hexobion
Hydoxin
I02-1897
I02-2297
KST-1A8556
LS-134393
LS-187072
LS-2332
MLS001074329
MLS002153915
MolPort-002-137-856
MolPort-002-319-991
MolPort-005-933-330
NCGC00016261-01
NCGC00164317-01
NCGC00180946-01
NSC 36225
NSC36225
NSC36225 (HCL)
Nestrex
Oprea1_061614
P0561
P4722_SIAL
P5669_SIGMA
P6280_SIGMA
P8666_SIGMA
P9755_SIAL
PN
PN HCl
PYRIDOXINE HYDROCHLORIDE
PYRIDOXINE HYDROCHLORIDE, U.S.P.
Paxadon
Piridossina
Piridossina [DCIT]
Piridoxina
Piridoxina [INN-Spanish]
Prestwick0_000623
Prestwick1_000623
Prestwick2_000623
Prestwick3_000623
Prestwick_925
Pydox
Pyridipca
Pyridox
Pyridoxin
Pyridoxin hydrochloride
Pyridoxine
Pyridoxine (INN)
Pyridoxine HCl
Pyridoxine Hydrochloride (B6)
Pyridoxine [INN:BAN]
Pyridoxine chloride
Pyridoxine hydrochloride (JP15/USP)
Pyridoxine hydrochloride [USAN:JAN]
Pyridoxine hydrogen chloride
Pyridoxine monohydrochloride
Pyridoxine, hydrochloride
Pyridoxine-HCl Microencapsulated
Pyridoxinium chloride
Pyridoxinum
Pyridoxinum [INN-Latin]
Pyridoxinum hydrochloricum
Pyridoxinum hydrochloricum (Hungarian)
Pyridoxol
Pyridoxol hydrochloride
Pyridoxol, hydrochloride
Pyridoxolum
Rodex
Rodex (R)
Rodex TD
SMP2_000230
SMR000674613
SPBio_002805
STK177324
STOCK1N-08684
Spondylonal
Tex Six T.R.
TimTec1_000657
UNII-68Y4CF58BV
UNII-KV2JZ1BI6Z
Vitamin B 6
Vitamin B6
Vitamin B6-hydrochloride
Vitamin V6
Vitamin V6 (TN)
Vitamin-?B6
Vitamin-?B6 hydrochloride
Vitaped
WLN: T6NJ B1 CQ D1Q E1Q &GH
ZINC00049154
ZINC21983293
bmse000288
c1302
component of Alestrol
nchembio.93-comp1
pyridoxine
vitamin B6
21
Pyridoxalapproved, nutraceuticalPhase 4, Phase 3, Phase 218766-72-81050
Synonyms:
2-methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine
3-Hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde
3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxaldehyde
 
3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde
3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde
Piridoxal
Pyridoxal
Pyridoxaldehyde
22Immunosuppressive AgentsPhase 4, Phase 3, Phase 213086
23Antiprotozoal AgentsPhase 4, Phase 3, Phase 2, Phase 12051
24Antiparasitic AgentsPhase 4, Phase 3, Phase 2, Phase 12199
25BenzonidazolePhase 4, Phase 3, Phase 212
26Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 122062
27Adrenergic alpha-1 Receptor AntagonistsPhase 4480
28Adrenergic AgentsPhase 4, Phase 35352
29Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug CombinationPhase 4, Phase 367
30AntimetabolitesPhase 4, Phase 3, Phase 212054
31Emtricitabine, Tenofovir Disoproxil Fumarate Drug CombinationPhase 4, Phase 3248
32Reverse Transcriptase InhibitorsPhase 4, Phase 3, Phase 21913
33Lipid Regulating AgentsPhase 4, Phase 3, Phase 22766
34Raltegravir PotassiumPhase 4, Phase 3, Phase 2292
35Cytochrome P-450 CYP2C9 InhibitorsPhase 4, Phase 3, Phase 2669
36Peripheral Nervous System AgentsPhase 4, Phase 323689
37Atazanavir SulfatePhase 4, Phase 3, Phase 2223
38Vitamin B 6Phase 4, Phase 3, Phase 2188
39Integrase InhibitorsPhase 4, Phase 3, Phase 2418
40HIV Integrase InhibitorsPhase 4, Phase 3, Phase 2397
41Lamivudine, zidovudine drug combinationPhase 4, Phase 3112
42Hypolipidemic AgentsPhase 4, Phase 3, Phase 22785
43HIV Protease InhibitorsPhase 4, Phase 2, Phase 35470
44Antibiotics, AntitubercularPhase 4, Phase 2, Phase 37180
45Anti-HIV AgentsPhase 4, Phase 2, Phase 33162
46Anti-Retroviral AgentsPhase 4, Phase 2, Phase 33296
47Natriuretic Peptide, BrainPhase 4182
48Neurotransmitter AgentsPhase 4, Phase 3, Phase 218340
49Anti-Bacterial AgentsPhase 4, Phase 2, Phase 311226
50AnticoagulantsPhase 42623

Interventional clinical trials:

(show top 50)    (show all 106)
idNameStatusNCT IDPhase
1Optimization of PCR Technique to Assess Parasitological Response for Patients With Chronic Chagas DiseaseUnknown statusNCT01678599Phase 4
2Population Pharmacokinetics Study of Benznidazole in Children With Chagas'DiseaseUnknown statusNCT01549236Phase 4
3Population Pharmacokinetics in Benznidazole-treated Adults With Chronic With Chagas DiseaseCompletedNCT01755403Phase 4
4Exercise Training in Chagas CardiomyopathyCompletedNCT01006473Phase 4
5A Randomized Trial of Carvedilol in Chronic Chagas CardiomyopathyCompletedNCT01557140Phase 4
6Outcomes of an Anticoagulation Clinic in an University HospitalCompletedNCT01006486Phase 4
7An Evaluation of the Pharmacological Interaction of Lopinavir/r and RifampinCompletedNCT00771498Phase 4
8Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for TuberculosisCompletedNCT00108862Phase 4
9Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During PregnancyCompletedNCT00605098Phase 4
10HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIVCompletedNCT00442962Phase 4
11REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) TreatmentCompletedNCT01380080Phase 4
12Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited SettingsCompletedNCT00084136Phase 4
13Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)RecruitingNCT01650792Phase 4
14A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral FailureActive, not recruitingNCT01641367Phase 4
15Reveal Chagas: Clinical Evidence of the Implantable Cardiac Monitor in Patients With Chagas DiseaseTerminatedNCT01539161Phase 4
16Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mgTerminatedNCT00533390Phase 4
17BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' DiseaseUnknown statusNCT00123916Phase 3
18Etiologic Treatment With Benznidazole in Adult Patients With Chronic Chagas Disease. A Randomized Clinical TrialCompletedNCT02386358Phase 3
19Cardiac Rehabilitation in Chagas Heart FailureCompletedNCT02516293Phase 2, Phase 3
20Chagas Cardiomyopathy Bisoprolol Intervention Study: CharityCompletedNCT00323973Phase 3
21Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease InhibitorCompletedNCT00038519Phase 2, Phase 3
22Preventing Sexual Transmission of HIV With Anti-HIV DrugsCompletedNCT00074581Phase 3
23Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and WomenCompletedNCT01461096Phase 3
24Study of Options for Second-Line Effective Combination Therapy (SELECT)CompletedNCT01352715Phase 3
25A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV TreatmentCompletedNCT00004581Phase 3
26A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug TherapyCompletedNCT00004583Phase 3
27Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive AdultsCompletedNCT01108510Phase 3
28Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected SubjectsCompletedNCT00146328Phase 2, Phase 3
29Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.CompletedNCT01991899Phase 3
30Prospective Study of a Pediatric Nifurtimox Formulation for Chagas' DiseaseRecruitingNCT02625974Phase 3
31Selenium Treatment and Chagasic Cardiopathy (STCC)RecruitingNCT00875173Phase 3
32CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY)RecruitingNCT02369978Phase 2, Phase 3
33Low Antimonial Dosage in American Mucosal LeishmaniasisRecruitingNCT01301937Phase 2, Phase 3
34Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected AdultsRecruitingNCT02344290Phase 3
35TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening RegimensRecruitingNCT02410772Phase 3
36Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid TreatmentRecruitingNCT02548351Phase 3
37Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KSRecruitingNCT01435018Phase 3
38Physical Exercise Program in Chronic Chagas Heart DiseaseActive, not recruitingNCT02517632Phase 3
39Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous LeishmaniasisActive, not recruitingNCT01301924Phase 2, Phase 3
40Evaluating the Safety and Effectiveness of Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis InfectionActive, not recruitingNCT01404312Phase 3
41Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's SarcomaActive, not recruitingNCT01352117Phase 3
42Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal ImpairmentActive, not recruitingNCT01818596Phase 3
43Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?Active, not recruitingNCT00860977Phase 3
44Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive ParticipantsActive, not recruitingNCT01815736Phase 3
45Treatment of Asymptomatic Toxocariasis With Albendazole in ChildrenActive, not recruitingNCT00755560Phase 3
46Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African TrypanosomiasisTerminatedNCT00330148Phase 3
47Cell Therapy in Chagas CardiomyopathyTerminatedNCT00349271Phase 3
48Proof-of-Concept Study of E1224 to Treat Adult Patients With Chagas DiseaseUnknown statusNCT01489228Phase 2
49Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected AdultsUnknown statusNCT01155037Phase 2
50A Study of the Use of Oral Posaconazole (POS) in the Treatment of Asymptomatic Chronic Chagas Disease (P05267)CompletedNCT01377480Phase 2

Search NIH Clinical Center for Chagas Disease

Genetic Tests for Chagas Disease

About this section

Anatomical Context for Chagas Disease

About this section

MalaCards organs/tissues related to Chagas Disease:

36
Heart, Testes, Eye, Colon, Lymph node, T cells, Skin

Publications for Chagas Disease

About this section

Articles related to Chagas Disease:

(show top 50)    (show all 806)
idTitleAuthorsYear
1
Triatoma vitticeps subcomplex (Hemiptera, Reduviidae, Triatominae): a new grouping of Chagas disease vectors from South America. (28407782)
2017
2
Interdisciplinary approach at the primary healthcare level for Bolivian immigrants with Chagas disease in the city of SALo Paulo. (28333923)
2017
3
Chagas disease in Europe: A review for the internist in the globalized world. (28502864)
2017
4
Challenges in the management of Chagas disease in Latin-American migrants in Europe. (28428122)
2017
5
Molecular and serological detection of Trypanosoma cruzi in dogs (Canis lupus familiaris) suggests potential transmission risk in areas of recent acute Chagas disease outbreaks in Colombia. (28532988)
2017
6
Prevalence of Chagas Disease in a U.S. Population of Latin American Immigrants with Conduction Abnormalities on Electrocardiogram. (28056014)
2017
7
Chagas disease: national survey of seroprevalence in children under five years of age conducted in 2008. (28443980)
2017
8
Modeling Chagas disease in Chile: From vector to congenital transmission. (28435013)
2017
9
Temporal Variation in the Abundance and Timing of Daily Activity of Chagas Disease Vector Triatoma gerstaeckeri (StAYl, 1859) in a Natural Habitat in the Lower Rio Grande Valley, South Texas. (28530845)
2017
10
Ten years of Chagas disease research: Looking back to achievements, looking ahead to challenges. (28426735)
2017
11
Towards improving early diagnosis of congenital Chagas disease in an endemic setting. (28369287)
2017
12
Chagas disease immunogenetics: elusive markers of disease progression. (28388241)
2017
13
The process of lipid storage in insect oocytes: The involvement of I^-chain of ATP synthase in lipophorin-mediated lipid transfer in the chagas' disease vector Panstrongylus megistus (Hemiptera: Reduviidae). (27983943)
2017
14
Chagas disease research and development: Is there light at the end of the tunnel? (28066534)
2017
15
Participation of TLR2 and TLR4 in Cytokines Production by Patients with Symptomatic and Asymptomatic Chronic Chagas Disease. (27783847)
2017
16
Understanding transmissibility patterns of Chagas disease through complex vector-host networks. (28077180)
2017
17
Autochthonous Chagas disease in the southern United States: A case report of suspected residential and military exposures. (28418113)
2017
18
Access to Chagas disease treatment in non-endemic countries: the case of Spain. (28495262)
2017
19
Genetic Polymorphisms of IL17 and Chagas Disease in the South and Southeast of Brazil. (28470012)
2017
20
The Evolutionary Origin of Diversity in Chagas Disease Vectors. (27986547)
2017
21
Development of Diagnostics for Chagas Disease: Where Should We Put Our Limited Resources? (28056025)
2017
22
The Prevalence of Trypanosoma cruzi, the Causal Agent of Chagas Disease, in Texas Rodent Populations. (28091763)
2017
23
Unraveling Chagas disease transmission through the oral route: Gateways to Trypanosoma cruzi infection and target tissues. (28379959)
2017
24
The Prevalence of Chagas Disease Among Latin American Immigrants with Pacemakers in Los Angeles, California. (28500812)
2017
25
Automated identification of insect vectors of Chagas disease in Brazil and Mexico: the Virtual Vector Lab. (28439451)
2017
26
Evaluation of P2X7 receptor expression in peripheral lymphocytes and immune profile from patients with indeterminate form of Chagas disease. (28062289)
2017
27
Leishmanicidal and Trypanocidal Activity of Metal Complexes with 1,2,4-Triazolo[1,5-a]pyrimidines: Insights on their Therapeutic Potential against Leishmaniasis and Chagas Disease. (28521698)
2017
28
Regarding Perspective Piece from July 2016 "What Do We Know About Chagas Disease in the United States? (28471741)
2017
29
Rapid diagnostic tests duo as alternative to conventional serological assays for conclusive Chagas disease diagnosis. (28369081)
2017
30
The molecular sensory machinery of a Chagas disease vector: expression changes through imaginal moult and sexually dimorphic features. (28059141)
2017
31
Performance Assessment of Four Chimeric Trypanosoma cruzi Antigens Based on Antigen-Antibody Detection for Diagnosis of Chronic Chagas Disease. (27517281)
2016
32
Advances and Progress in Chagas Disease Drug Discovery. (27072717)
2016
33
Community resilience and Chagas disease in a rural region of Mexico. (27509012)
2016
34
Serological Diagnosis of Chronic Chagas Disease: Is It Time for a Change? (27053668)
2016
35
Orally-transmitted Chagas disease. (27993415)
2016
36
Acute colonic complications in a patient with Chagas disease. (27128343)
2016
37
Oesophageal motility disorders in infected immigrants with Chagas disease in a non-endemic European area. (27536373)
2016
38
IL18 Gene Variants Influence the Susceptibility to Chagas Disease. (27027876)
2016
39
Morphological and Genetic Differentiation within the Southernmost Vector of Chagas Disease: Triatoma patagonica (Hemiptera - Reduviidae). (28005972)
2016
40
PHARMACOKINETICS OF BENZNIDAZOLE IN CHAGAS DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. (27550362)
2016
41
Scrutinizing the Biomarkers for the Neglected Chagas Disease: How Remarkable! (27563302)
2016
42
Trypanosoma cruzi Infection Prevalence and Bloodmeal Analysis in Triatomine Vectors of Chagas Disease From Rural Peridomestic Locations in Texas, 2013-2014. (27106934)
2016
43
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness. (27501246)
2016
44
New cases of Chagas disease in a rural area of Northeast Brazilian. (27192597)
2016
45
Chronic Heart Disease after Treatment of Oral Acute Chagas Disease. (27627643)
2016
46
Benznidazole therapy for Chagas disease in asymptomatic Trypanosoma cruzi -seropositive former blood donors: evaluation of the efficacy of different treatment regimens. (28001218)
2016
47
Chagas' disease in Aboriginal and Creole communities from the Gran Chaco Region of Argentina: Seroprevalence and molecular parasitological characterization. (27057620)
2016
48
Flavonoids and Chagas' disease: the story so far! (27558676)
2016
49
Analysis of Regional Left Ventricular Strain in Patients with Chagas Disease and Normal Left Ventricular Systolic Function. (27086044)
2016
50
A Deep Insight into the Sialome of Rhodnius neglectus, a Vector of Chagas Disease. (27129103)
2016

Variations for Chagas Disease

About this section

Expression for genes affiliated with Chagas Disease

About this section
Search GEO for disease gene expression data for Chagas Disease.

Pathways for genes affiliated with Chagas Disease

About this section

Pathways related to Chagas Disease according to KEGG:

34
id Name KEGG Source Accession
1Chagas disease (American trypanosomiasis)hsa05142

Pathways related to Chagas Disease according to GeneCards Suite gene sharing:

(show top 50)    (show all 92)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.9IFNG, IL2, TNF
29.9IFNG, IL10, IL2
39.9IFNG, IL10, IL2
49.9CCL2, IL1B, TNF
59.9IL1B, IL6, TNF
69.8IFNG, IL2, TGFB1
79.8IFNG, IL2, TGFB1
89.8IFNG, IL1B, NOS2
99.8CXCL8, IL6, TNF
109.8IL1B, IL6, TGFB1
119.8CCL2, CXCL8, IL6
129.7IFNG, IL2, IL6, TNF
139.7CCL2, IFNG, IL1B, TNF
149.7CCL2, IFNG, IL1B, TLR2
159.7CCL2, IL1B, IL6, TNF
16
Show member pathways
9.6IL1B, IL2, TLR2, TLR4
17
Show member pathways
9.6CXCL8, IFNG, IL2, TNF
189.6IFNG, IL1B, TGFB1, TNF
199.6IFNG, IL6, NOS2, TLR4
209.6CXCL8, IFNG, IL2, IL6
219.6IFNG, IL10, IL2, IL6, TNF
229.6CXCL8, IL1B, TLR4, TNF
239.6IFNG, IL10, IL1B, IL2, TNF
249.5CXCL8, IFNG, IL6, NOS2
25
Show member pathways
9.5IFNG, SMAD2, TGFB1, TNF
26
Show member pathways
9.5IFNG, SMAD2, TGFB1, TNF
27
Show member pathways
9.5IFNG, IL10, IL2, TGFB1, TNF
289.5CXCL8, IL2, TGFB1, TLR4
29
Show member pathways
9.5IL10, IL6, SMAD2, TGFB1
309.5IL10, IL1B, IL6, TLR4, TNF
319.5CXCL8, IL6, NOS2, TGFB1
32
Show member pathways
9.4IFNG, IL10, IL12B, IL2, TNF
339.4IFNG, IL10, IL12B, IL2, IL6
34
Show member pathways
9.4IFNG, IL10, IL12B, IL2, IL6
359.4CXCL8, IL10, IL1B, IL6, TNF
369.4IFNG, IL12B, IL1B, IL6, TNF
37
Show member pathways
9.4ADRB1, IL6, TGFB1, TNF
38
Show member pathways
9.4CXCL8, IL6, TLR2, TLR4, TNF
39
Show member pathways
9.3IL12B, IL1B, TLR2, TLR4, TNF
40
Show member pathways
9.3CCL2, IFNG, IL1B, IL2, IL6, TNF
419.3CXCL8, IFNG, IL1B, IL6, TGFB1
429.3CALR, IFNG, IL1B, IL6, TNF
439.2IFNG, IL10, IL12B, IL1B, IL6, TNF
449.2CCL2, IFNG, IL10, IL1B, IL2, TLR2
459.1IFNG, IL12B, IL1B, IL2, TGFB1, TNF
469.1CXCL8, IL6, NOS2, SMAD2, TGFB1
47
Show member pathways
9.1CXCL8, IFNG, IL1B, IL6, NOS2, TLR4
48
Show member pathways
9.1CXCL8, IFNG, IL12B, IL1B, IL6, TNF
499.1IFNG, IL10, IL1B, IL2, IL6, TGFB1
50
Show member pathways
9.0CCL2, CXCL8, IFNG, IL1B, IL6, TLR2

GO Terms for genes affiliated with Chagas Disease

About this section

Cellular components related to Chagas Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098979.7CALR, CCR5, IFNG, IL6, TLR4, TNF
2cell surfaceGO:00099869.6CALR, CCR5, TGFB1, TLR2, TLR4, TNF
3extracellular regionGO:00055768.3CALR, CCL2, CXCL8, IFNG, IL10, IL12B
4extracellular spaceGO:00056157.6CALR, CCL2, CXCL8, IFNG, IL10, IL12B

Biological processes related to Chagas Disease according to GeneCards Suite gene sharing:

(show top 50)    (show all 108)
idNameGO IDScoreTop Affiliating Genes
1endothelial cell apoptotic processGO:007257710.9IL10, TNF
2negative regulation of cytokine secretion involved in immune responseGO:000274010.9IL10, TNF
3epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.9IL6, TNF
4positive regulation of isotype switching to IgG isotypesGO:004830410.9IFNG, IL2
5negative regulation of lipid storageGO:001088810.9IL6, TNF
6neutrophil apoptotic processGO:000178110.9IFNG, IL6
7positive regulation of fever generationGO:003162210.9IL1B, TNF
8cellular response to lipoteichoic acidGO:007122310.9TLR2, TLR4
9positive regulation of interleukin-8 biosynthetic processGO:004541610.9TLR4, TNF
10receptor biosynthetic processGO:003280010.9IL10, TNF
11positive regulation of interleukin-6 biosynthetic processGO:004541010.9IFNG, IL1B
12positive regulation of vitamin D biosynthetic processGO:006055710.9IFNG, TNF
13positive regulation of interleukin-12 biosynthetic processGO:004508410.8IFNG, TLR4
14positive regulation of killing of cells of other organismGO:005171210.8IFNG, NOS2
15positive regulation of mononuclear cell migrationGO:007167710.8TGFB1, TNF
16positive regulation of leukocyte mediated cytotoxicityGO:000191210.8CCL2, NOS2
17regulation of establishment of endothelial barrierGO:190314010.8IL1B, TNF
18positive regulation of regulatory T cell differentiationGO:004559110.8IL2, TGFB1
19regulation of defense response to virus by hostGO:005069110.8IFNG, IL1B
20regulation of vascular endothelial growth factor productionGO:001057410.8CCL2, IL6
21positive regulation of smooth muscle cell apoptotic processGO:003439310.7IFNG, IL12B
22positive regulation of tissue remodelingGO:003410510.7IL12B, IL2
23positive regulation of granulocyte macrophage colony-stimulating factor productionGO:003272510.7IL12B, IL1B
24defense response to Gram-positive bacteriumGO:005083010.7IL6, TLR2, TNF
25cellular response to estradiol stimulusGO:007139210.7CCL2, IL10, IL6
26positive regulation of lymphocyte proliferationGO:005067110.7IL12B, TLR4
27positive regulation of calcidiol 1-monooxygenase activityGO:006055910.7IFNG, IL1B, TNF
28positive regulation of heterotypic cell-cell adhesionGO:003411610.7IL10, IL1B, TNF
29positive regulation of chemokine biosynthetic processGO:004508010.7IFNG, IL1B, TNF
30negative regulation of interleukin-6 productionGO:003271510.7IL10, TLR4, TNF
31positive regulation of membrane protein ectodomain proteolysisGO:005104410.7IFNG, IL1B, TNF
32common-partner SMAD protein phosphorylationGO:000718210.7SMAD2, TGFB1
33positive regulation of MHC class II biosynthetic processGO:004534810.7IFNG, IL10, TLR4
34extrinsic apoptotic signaling pathwayGO:009719110.7IFNG, TGFB1, TNF
35negative regulation of mitotic cell cycleGO:004593010.7IL10, TGFB1, TNF
36positive regulation of JNK cascadeGO:004633010.6IL1B, TLR4, TNF
37positive regulation of protein complex assemblyGO:003133410.6IFNG, TGFB1, TNF
38cellular response to drugGO:003569010.6CCL2, IL1B, NOS2
39positive regulation of nitric-oxide synthase biosynthetic processGO:005177010.6CCL2, TLR2, TLR4
40negative regulation of fat cell differentiationGO:004559910.6IL6, TGFB1, TNF
41cellular response to dexamethasone stimulusGO:007154910.6CCL2, IL6, TGFB1
42positive regulation of peptidyl-serine phosphorylationGO:003313810.6IL6, TGFB1, TNF
43protein import into nucleus, translocationGO:000006010.6IFNG, TGFB1, TNF
44regulation of bindingGO:005109810.6SMAD2, TGFB1
45positive regulation of osteoclast differentiationGO:004567210.6IFNG, IL12B, TNF
46cellular response to interleukin-1GO:007134710.6CCL2, CXCL8, IL6
47cellular response to mechanical stimulusGO:007126010.6IL1B, TGFB1, TLR4
48response to insulinGO:003286810.5IL10, IL6, TLR2
49cellular response to interferon-gammaGO:007134610.5CCL2, IL12B, NOS2
50humoral immune responseGO:000695910.5CCL2, IFNG, IL6, TNF

Molecular functions related to Chagas Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1lipopolysaccharide receptor activityGO:000187510.3TLR2, TLR4
2type I transforming growth factor beta receptor bindingGO:00347139.9SMAD2, TGFB1
3growth factor activityGO:00080839.6IL10, IL12B, IL2, IL6, TGFB1
4cytokine activityGO:00051258.8CCL2, CXCL8, IFNG, IL10, IL12B, IL1B

Sources for Chagas Disease

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet